HIV/HBV/HCV Test Kits Market

FMI is of the opinion that supplier preference will be decided by assay reliability, specimen compatibility, and channel-level accessibility, as providers and public health buyers place greater emphasis on diagnostic accuracy, workflow fit, and broad testing reach across infectious disease screening pathways.